Publications by authors named "Adam Cheknis"

Claim this Profile
E
Epidemiology of infection at one hospital 10 years after an outbreak of the epidemic strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures.
Jeffrey T Wieczorkiewicz, Andrew M Skinner, Adam Cheknis, Laurica A Petrella, Vanessa W Stevens

Antimicrob Agents Chemother· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of infection after a change in the diagnostic testing algorithm.
Andrew S Crone, Lorinda M Wright, Adam Cheknis, Stuart Johnson, Susan M Pacheco

Infect Control Hosp Epidemiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial susceptibility of Clostridioides difficile to omadacycline and comparator antimicrobials.
Andrew M Skinner, Laurica A Petrella, Adam Cheknis, Stuart Johnson

J Antimicrob Chemother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the COVID-19 Pandemic on Rates and Epidemiology of Infection in One VA Hospital.
Lorinda M Wright, Andrew M Skinner, Adam Cheknis, Conor McBurney, Ling Ge

Antibiotics (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of toxin gene transfer from Clostridioides difficile strain 630Δerm to nontoxigenic C. difficile strain NTCD-M3r in filter mating experiments.
Susan P Sambol, Stuart Johnson, Adam Cheknis, Dale N Gerding

PLoS One· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.
Adam Cheknis, Dominique Devaris, Laurent Chesnel, Suzanne E Dale, Julia Nary

J Antimicrob Chemother· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential introduction of a multistep testing algorithm and nucleic acid amplification testing leading to an increase in detection and a trend toward increased strain diversity.
Andrew M Skinner, Brian Yu, Adam Cheknis, Susan M Pacheco, Dale N Gerding

Infect Control Hosp Epidemiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015.
Adam Cheknis, Stuart Johnson, Laurent Chesnel, Laurica Petrella, Susan Sambol

Anaerobe· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors.
Alice von Eichel-Streiber, Wonbeom Paik, Katherine Knight, Karina Gisch, Karolina Nadjafi, Adam Cheknis

Anaerobe· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027.
Jeffrey T Wieczorkiewicz, Bert K Lopansri, Adam Cheknis, James R Osmolski, David W Hecht

Antimicrob Agents Chemother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
Glen P Carter, Anjana Chakravorty, Tu Anh Pham Nguyen, Steven Mileto, Fernanda Schreiber, Adam Cheknis

mBio· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile.
Kristin J Nagaro, S Tyler Phillips, Adam K Cheknis, Susan P Sambol, Walter E Zukowski

Antimicrob Agents Chemother· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.
Laurica A Petrella, Susan P Sambol, Adam Cheknis, Kristin Nagaro, Yin Kean

Clin Infect Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.
Farida Siddiqui, Jennifer R O'Connor, Kristin Nagaro, Adam Cheknis, Susan P Sambol

J Infect Dis· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.
Adam K Cheknis, Susan P Sambol, David M Davidson, Kristin J Nagaro, Maria C Mancini

Anaerobe· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mouse model of Clostridium difficile-associated disease.
Xinhua Chen, Kianoosh Katchar, Jeffrey D Goldsmith, Nanda Nanthakumar, Adam Cheknis

Gastroenterology· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection of hamsters with historical and epidemic BI types of Clostridium difficile.
Nadia Razaq, Susan Sambol, Kristin Nagaro, Walter Zukowski, Adam Cheknis

J Infect Dis· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis